Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Notter

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 1987
Alveolar epithelial changes in rabbits after a 21-day exposure to 60% O2B A Holm, R H Notter, J F Leary, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1988
Type II pneumocyte changes during hyperoxic lung injury and recoveryB A Holm, S Matalon, J N Finkelstein, et al.
The Journal of Biological Chemistry|October 25, 1986
Phospholipid binding and biophysical activity of pulmonary surfactant-associated protein (SAP)-35 and its non-collagenous COOH-terminal domainsG F Ross, R H Notter, J Meuth, et al.
Pediatric Research|May 1, 1996
Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activityB A Holm, Z Wang, E A Egan, et al.
Pediatric Research|September 1, 1983
Ultrasonic and jet aerosolization of phospholipids and the effects on surface activityL B Marks, R H Notter, G Oberdorster, et al.
Chemistry and Physics of Lipids|June 1, 1987
Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoproteinR H Notter, D L Shapiro, B Ohning, et al.
Chemistry and Physics of Lipids|February 1, 1990
Biophysical inhibition of synthetic lung surfactantsB A Holm, A R Venkitaraman, G Enhorning, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 12, 2002
Content-dependent activity of lung surfactant protein B in mixtures with lipidsZ Wang, J E Baatz, B A Holm, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 19, 2003
Combined-modality therapy with inhaled nitric oxide and exogenous surfactant in term infants with acute respiratory failureI P Uy, G S Pryhuber, P R Chess, et al.
Pediatrics|October 1, 1985
Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infantsM S Kwong, E A Egan, R H Notter, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Journal of Applied Physiology (Bethesda, Md. : 1985)|June 1, 1987
Alveolar epithelial changes in rabbits after a 21-day exposure to 60% O2B A Holm, R H Notter, J F Leary, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 1, 1988
Type II pneumocyte changes during hyperoxic lung injury and recoveryB A Holm, S Matalon, J N Finkelstein, et al.
The Journal of Biological Chemistry|October 25, 1986
Phospholipid binding and biophysical activity of pulmonary surfactant-associated protein (SAP)-35 and its non-collagenous COOH-terminal domainsG F Ross, R H Notter, J Meuth, et al.
Pediatric Research|May 1, 1996
Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activityB A Holm, Z Wang, E A Egan, et al.
Pediatric Research|September 1, 1983
Ultrasonic and jet aerosolization of phospholipids and the effects on surface activityL B Marks, R H Notter, G Oberdorster, et al.
Chemistry and Physics of Lipids|June 1, 1987
Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoproteinR H Notter, D L Shapiro, B Ohning, et al.
Chemistry and Physics of Lipids|February 1, 1990
Biophysical inhibition of synthetic lung surfactantsB A Holm, A R Venkitaraman, G Enhorning, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 12, 2002
Content-dependent activity of lung surfactant protein B in mixtures with lipidsZ Wang, J E Baatz, B A Holm, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|June 19, 2003
Combined-modality therapy with inhaled nitric oxide and exogenous surfactant in term infants with acute respiratory failureI P Uy, G S Pryhuber, P R Chess, et al.
Pediatrics|October 1, 1985
Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infantsM S Kwong, E A Egan, R H Notter, et al.
Pageof 9